Fluoxetine and citalopram decrease microglial release of glutamate and D-serine to promote cortical neuronal viability following ischemic insult
- PMID: 23876875
- DOI: 10.1016/j.mcn.2013.07.006
Fluoxetine and citalopram decrease microglial release of glutamate and D-serine to promote cortical neuronal viability following ischemic insult
Abstract
Depression is one of the most common disorders appearing following a stroke, and is also a major factor limiting recovery and rehabilitation in stroke patients. Antidepressants are the most common prescribed treatment for depression and have shown to have anti-inflammatory properties within the central nervous system (CNS). The major source of pro-inflammatory factors within the CNS is from activated microglia, the innate immune cells of the CNS. Antidepressants have been shown to promote midbrain and hippocampal neuronal survival following an ischemic insult and this survival is mediated through the anti-inflammatory effects on microglia, but the effects on cortical neuronal survival after this insult have yet to be investigated. The present study aimed to test and compare antidepressants from three distinct classes (tricyclics, monoamine oxidase inhibitors, and selective serotonin-reuptake inhibitors [SSRIs]) on the release of inflammatory factors and amino acids from activated microglia and whether altering this release could affect cortical neuronal viability after an ischemic insult. Primary microglia were treated with 1 μg/ml LPS and/or 10 μM antidepressants, and the various factors released into medium were assayed. Co-cultures consisting of microglia and primary cortical neurons were used to assess the effects of antidepressant-treated activated microglia on the viability of ischemic injured neurons. Of the antidepressants tested, most decreased the release of the proinflammatory factors nitric oxide, tumor necrosis factor-alpha, and interleukin 1-beta from activated microglia. Fluoxetine and citalopram, the SSRIs, decreased the release of the amino acids glutamate and d-serine from LPS-activated microglia. oxygen-glucose deprived (OGD) cortical neurons cocultured with LPS-activated microglia pre-treated with fluoxetine and citalopram showed greater survival compared to injured neurons co-cultured with untreated activated microglia. Microglial release of glutamate and d-serine was shown to be the most important factor mediating neuronal survival following antagonism studies. To our knowledge, our results demonstrate for the first time that fluoxetine and citalopram decrease the release of glutamate and d-serine from LPS-activated microglia and this causes an increase in the survival of OGD-injured cortical neurons after co-culture.
Keywords: Antidepressants; Depression; Excitotoxicity; Inflammation; Ischemic stroke; Microglia.
© 2013.
Similar articles
-
Fluoxetine and its metabolite norfluoxetine induce microglial apoptosis.J Neurochem. 2019 Mar;148(6):761-778. doi: 10.1111/jnc.14661. Epub 2019 Feb 12. J Neurochem. 2019. PMID: 30613984
-
HAMI 3379, a CysLT2 receptor antagonist, attenuates ischemia-like neuronal injury by inhibiting microglial activation.J Pharmacol Exp Ther. 2013 Aug;346(2):328-41. doi: 10.1124/jpet.113.203604. Epub 2013 Jun 7. J Pharmacol Exp Ther. 2013. PMID: 23750020
-
Fluoxetine and S-citalopram inhibit M1 activation and promote M2 activation of microglia in vitro.Neuroscience. 2015 May 21;294:60-8. doi: 10.1016/j.neuroscience.2015.02.028. Epub 2015 Feb 21. Neuroscience. 2015. PMID: 25711936
-
Speculations on difference between tricyclic and selective serotonin reuptake inhibitor antidepressants on their cardiac effects. Is there any?Curr Med Chem. 1999 Jun;6(6):469-80. Curr Med Chem. 1999. PMID: 10213794 Review.
-
Modulation of microglial activation by antidepressants.J Psychopharmacol. 2022 Feb;36(2):131-150. doi: 10.1177/02698811211069110. Epub 2022 Jan 29. J Psychopharmacol. 2022. PMID: 35098788 Free PMC article. Review.
Cited by
-
Statin treatment affects cytokine release and phagocytic activity in primary cultured microglia through two separable mechanisms.Mol Brain. 2014 Nov 26;7:85. doi: 10.1186/s13041-014-0085-7. Mol Brain. 2014. PMID: 25424483 Free PMC article.
-
GABAergic Inhibitory Interneuron Deficits in Alzheimer's Disease: Implications for Treatment.Front Neurosci. 2020 Jun 30;14:660. doi: 10.3389/fnins.2020.00660. eCollection 2020. Front Neurosci. 2020. PMID: 32714136 Free PMC article. Review.
-
Delayed citalopram administration reduces brain inflammation and enhances skilled motor function after ischaemic stroke in 'MacGreen' mice.Eur J Neurosci. 2022 Mar;55(5):1344-1355. doi: 10.1111/ejn.15601. Epub 2022 Feb 7. Eur J Neurosci. 2022. PMID: 35060208 Free PMC article.
-
From "Leaky Gut" to Impaired Glia-Neuron Communication in Depression.Adv Exp Med Biol. 2021;1305:129-155. doi: 10.1007/978-981-33-6044-0_9. Adv Exp Med Biol. 2021. PMID: 33834399
-
Novel metabolic biomarkers for the diagnosis of acute ischemic stroke.Biomark Med. 2024;18(17-18):727-737. doi: 10.1080/17520363.2024.2389033. Epub 2024 Sep 5. Biomark Med. 2024. PMID: 39235047
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical